NO841519L - Perfluorkarbon-emulsjoner for anvendelse i terapi, samt fremgangsmaate for fremstilling av slike emulsjoner - Google Patents

Perfluorkarbon-emulsjoner for anvendelse i terapi, samt fremgangsmaate for fremstilling av slike emulsjoner

Info

Publication number
NO841519L
NO841519L NO841519A NO841519A NO841519L NO 841519 L NO841519 L NO 841519L NO 841519 A NO841519 A NO 841519A NO 841519 A NO841519 A NO 841519A NO 841519 L NO841519 L NO 841519L
Authority
NO
Norway
Prior art keywords
emulses
emulsions
therapy
procedures
preparation
Prior art date
Application number
NO841519A
Other languages
English (en)
Norwegian (no)
Inventor
John M Yuhas
Robert L Goodman
Robert E Moore
Original Assignee
Sun Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO841519(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sun Tech Inc filed Critical Sun Tech Inc
Publication of NO841519L publication Critical patent/NO841519L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO841519A 1982-08-17 1984-04-16 Perfluorkarbon-emulsjoner for anvendelse i terapi, samt fremgangsmaate for fremstilling av slike emulsjoner NO841519L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40858982A 1982-08-17 1982-08-17
US51715083A 1983-07-25 1983-07-25

Publications (1)

Publication Number Publication Date
NO841519L true NO841519L (no) 1984-04-16

Family

ID=27020315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841519A NO841519L (no) 1982-08-17 1984-04-16 Perfluorkarbon-emulsjoner for anvendelse i terapi, samt fremgangsmaate for fremstilling av slike emulsjoner

Country Status (19)

Country Link
EP (1) EP0105584B1 (es)
JP (1) JPS59501665A (es)
KR (1) KR890002204B1 (es)
AU (1) AU559559B2 (es)
CA (1) CA1225027A (es)
CH (1) CH665952A5 (es)
DE (2) DE3378954D1 (es)
ES (1) ES524972A0 (es)
FI (1) FI841513A (es)
GB (1) GB2134787A (es)
GR (1) GR79383B (es)
IE (1) IE55618B1 (es)
IL (1) IL69505A (es)
NL (1) NL8320264A (es)
NO (1) NO841519L (es)
PH (2) PH25492A (es)
PT (1) PT77204B (es)
SE (1) SE8402098L (es)
WO (1) WO1984000686A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
CA1257828A (en) * 1984-04-16 1989-07-25 William Mccormick Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation
US4815446A (en) * 1985-05-09 1989-03-28 Alpha Therapeutic Corporation Process for treating metastasis of cancerous tumors
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US4956390A (en) * 1987-08-25 1990-09-11 Air Products And Chemicals, Inc. Gas transport employing perfluorobutyldecalin
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
EP1100366B1 (en) * 1998-07-09 2009-04-15 Curelight Medical Ltd Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
US20040122492A1 (en) 1999-07-07 2004-06-24 Yoram Harth Phototherapeutic treatment of skin conditions
GB0200721D0 (en) * 2002-01-14 2002-02-27 Univ Bristol Toxicity test
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc THERAPIES USING ANTIFIBROBLASTIC FLUOROCHEMICAL EMULSIONS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828085A (en) * 1970-07-09 1974-08-06 Allied Chem Novel amidoamine oxides
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US4041086A (en) * 1972-02-07 1977-08-09 Sun Ventures, Inc. Process of manufacture of flourinated alkyladamantanes
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
JPS5331209B2 (es) * 1973-10-05 1978-09-01
DE2524363A1 (de) * 1975-06-02 1976-12-16 Boehringer Sohn Ingelheim Neue pharmazeutische mittel
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
JPS5331209A (en) * 1976-09-03 1978-03-24 Hitachi Ltd Small compressor cylinder for refrigerating machine and production of same
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
JPS6033367B2 (ja) * 1978-11-24 1985-08-02 株式会社ミドリ十字 酸素運搬輸液
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
WO1981000002A1 (en) * 1979-06-25 1981-01-08 Suntech Use of perfluorocarbon as burn treatment
CA1181011A (en) * 1980-05-27 1985-01-15 Robert P. Geyer Perfluorinated n,n-dimethyl cyclohexylmethylamine and emulsions containing the same
GR78151B (es) * 1982-04-05 1984-09-26 Alcon Lab Inc

Also Published As

Publication number Publication date
DE3390172T1 (de) 1984-11-29
IE831925L (en) 1984-02-17
DE3378954D1 (en) 1989-02-23
SE8402098D0 (sv) 1984-04-16
PT77204B (en) 1986-02-04
ES8502405A1 (es) 1985-01-01
WO1984000686A1 (en) 1984-03-01
CA1225027A (en) 1987-08-04
PT77204A (en) 1983-09-01
AU1941383A (en) 1984-03-07
IE55618B1 (en) 1990-11-21
CH665952A5 (de) 1988-06-30
JPS59501665A (ja) 1984-10-04
EP0105584A1 (en) 1984-04-18
IL69505A0 (en) 1983-11-30
EP0105584B1 (en) 1989-01-18
AU559559B2 (en) 1987-03-12
GB2134787A (en) 1984-08-22
FI841513A0 (fi) 1984-04-16
IL69505A (en) 1990-03-19
PH25492A (en) 1991-07-24
NL8320264A (nl) 1984-07-02
FI841513A (fi) 1984-04-16
KR840005660A (ko) 1984-11-15
GR79383B (es) 1984-10-22
KR890002204B1 (ko) 1989-06-23
PH25027A (en) 1991-01-28
SE8402098L (sv) 1984-04-16
ES524972A0 (es) 1985-01-01

Similar Documents

Publication Publication Date Title
NO841519L (no) Perfluorkarbon-emulsjoner for anvendelse i terapi, samt fremgangsmaate for fremstilling av slike emulsjoner
ZA804180B (en) Medicaments for the treatment of disorders in lipometabolism and their use
DK181983D0 (da) 1,8-naphthyridin- og 1,5,8-azanaphthyridin-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
FI874671A (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DK163277C (da) Anthracyklinglycosid-kardiolipinkompleks indkapslet i liposomer, fremgangsmaade til fremstilling heraf samt terapeutisk praeparat indeholdende dette
FI842912A (fi) Oftalmologisk kombinationsapparat foer diagnos och terapi.
GB2063668B (en) Beta-cyclodextrin for use in the treatment of acne
DK426083A (da) Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse
AU568483B2 (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infectious deseases of different types with the preparative use of alkaloid-compounds or their salts
IL64146A0 (en) Derivatives of thieno-pyridinone,the method of their preparation and their therapeutic use
NO175488C (no) Plasmider for regulerbart kopitall, samt anvendelse av slike
GB2098478B (en) Propioibacteria preparations for use in the treatment of tumours
ATE27599T1 (de) Rooperol und dessen derivate.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
NO844241L (no) Fremgangsmaate for konstruksjon av grunnmursfundament, samt forskaling til bruk ved fremgangsmaatens utfoerelse
DK364483A (da) 14-aminosteroid-derivater samt fremgangsmaade til fremstilling deraf
NO833355L (no) Fremgangsmaate ved behandling av trevirke, samt middel for anvendelse ved utoevelse av fremgangsmaaten
IT1170862B (it) Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1140547B (it) Apparecchiatura utilizzata nel trattamento di recipienti
IT8024877A0 (it) Reagente e metodo per determinare l'aldolasi di tipo muscolare umano.
IT8050469A0 (it) Tiocarnitine procedimento per la loro preparazione e loro uso terapeutico
IT8322499A0 (it) Cianalchilpiperazine procedimenti per la loro preparazione e loro impiego.
GB2019720B (en) Adenosyl-l-homocysteine and salts thereof for use in therapy
ZA83208B (en) The use of substituted chloro-s-triazines as selective agents against weeds and noxious grasses
Harasym The analysis of various techniques used for scoring patient management problems